Komipharm International's latest marketcap:
As of 08/02/2025, Komipharm International's market capitalization has reached $264.94 M. According to our data, Komipharm International is the 18522th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 264.94 M |
| Revenue (ttm) | 43.41 M |
| Net Income (ttm) | 8.92 M |
| Shares Out | 71.03 M |
| EPS (ttm) | 0.13 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 12/29/2003 |
| Earnings Date | 08/12/2025 |
Komipharm International's yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/02/2025 | ₩367.94 B | $264.94 M | 38.92% | 18522 |
| 12/30/2024 | ₩267.41 B | $179.17 M | -9.03% | 19660 |
| 12/28/2023 | ₩293.94 B | $226.34 M | -34.1% | 18073 |
| 12/29/2022 | ₩446.06 B | $352.38 M | -18.67% | 14533 |
| 12/30/2021 | ₩548.45 B | $460.7 M | -36.13% | 13872 |
| 12/30/2020 | ₩858.75 B | $790.05 M | -11.44% | 9121 |
| 12/30/2019 | ₩969.69 B | $833.93 M | -17.31% | 7607 |
| 12/28/2018 | ₩1.17 T | $1.04 B | -44.03% | 6004 |
| 12/28/2017 | ₩2.1 T | $1.95 B | 10.07% | 4666 |
| 12/29/2016 | ₩1.9 T | $1.56 B | -7.08% | 4717 |
Company Profile
About Komipharm International Co., Ltd.
Komipharm International Co., Ltd. is a leading manufacturer and supplier of veterinary and pharmaceutical products, with a focus on innovation in animal and human health.
Core Business Activities
- Veterinary Products: Produces vaccines, pharmaceuticals, and disinfectants in various forms, including injectables, powders, oral solutions, and topical solutions.
- Bio-Fertilizers: Develops eco-friendly agricultural solutions to enhance crop productivity.
- Human Health Research: Actively engaged in the development of anticancer drugs and pain-relieving agents.
- Clinical Services: Conducts pathological experiments, tests, and analyses to support medical and veterinary research.
Company Background
Originally established as Korea Microbiological Laboratories Co., Ltd. in 1972, the company rebranded to Komipharm International Co., Ltd. in September 2004. Headquartered in Siheung-Si, South Korea, Komipharm has built a strong reputation in both domestic and international markets.
Frequently Asked Questions
-
What is Komipharm International's (KOSDAQ-041960) current market cap?As of 08/02/2025, Komipharm International (including the parent company, if applicable) has an estimated market capitalization of $264.94 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Komipharm International (KOSDAQ-041960) rank globally by market cap?Komipharm International global market capitalization ranking is approximately 18522 as of 08/02/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.